aTYR PHARMA (ATYR) Leases (2019 - 2025)
aTYR PHARMA (ATYR) has disclosed Leases for 7 consecutive years, with $5.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Leases rose 363.42% year-over-year to $5.5 million, compared with a TTM value of $5.5 million through Dec 2025, up 363.42%, and an annual FY2025 reading of $5.5 million, up 363.42% over the prior year.
- Leases was $5.5 million for Q4 2025 at aTYR PHARMA, down from $5.6 million in the prior quarter.
- Across five years, Leases topped out at $7.2 million in Q4 2022 and bottomed at $827000.0 in Q2 2022.
- Average Leases over 5 years is $3.2 million, with a median of $1.9 million recorded in 2021.
- The sharpest move saw Leases skyrocketed 371.33% in 2022, then tumbled 84.95% in 2025.
- Year by year, Leases stood at $1.5 million in 2021, then surged by 390.2% to $7.2 million in 2022, then dropped by 7.21% to $6.7 million in 2023, then tumbled by 82.28% to $1.2 million in 2024, then soared by 363.42% to $5.5 million in 2025.
- Business Quant data shows Leases for ATYR at $5.5 million in Q4 2025, $5.6 million in Q3 2025, and $894000.0 in Q2 2025.